11 patents
Utility
Reducing Fratricide of Immune Cells Expressing NKG2D-BASED Receptors
2 Nov 23
The present application relates to the field of immunotherapy, more particularly to the manufacture of cells for adoptive cell therapy.
David GILHAM, Eytan BREMAN, Benjamin DEMOULIN, Simon BORNSCHEIN, Susanna RAITANO
Filed: 24 Mar 23
Utility
Improved Scaffolds for Multiplexed Inhibitory Rna
25 May 23
The present application relates to the field of RNA interference, more particularly RNA interference as applied in immunotherapy, such as adoptive cell therapy (ACT).
Mikhail STEKLOV, Eytan BREMAN, Peggy SOTIROPOULOU
Filed: 4 May 21
Utility
Reducing fratricide of immune cells expressing NKG2D-based receptors
2 May 23
The present application relates to the field of immunotherapy, more particularly to the manufacture of cells for adoptive cell therapy.
David Gilham, Eytan Breman, Benjamin Demoulin, Simon Bornschein, Susanna Raitano
Filed: 5 Dec 18
Utility
CD52-DEFICIENT Cells for Adoptive Cell Therapy
6 Oct 22
The present application relates to the field of immunotherapy, more particularly to the field of adoptive cell therapy (ACT).
Simon BORNSCHEIN, Eytan BREMAN
Filed: 18 Jun 20
Utility
Car T-cells Targeting Bcma and Uses Thereof
14 Jul 22
The present application relates to the field of immunotherapy, more particularly to the field of chimeric antigen receptors (CARs).
Simon BORNSCHEIN, Jennifer BOLSÉE, Peggy SOTIROPOULOU
Filed: 30 Apr 20
Utility
Cells with Multiplexed Inhibitory Rna
30 Jun 22
The present application relates to the field of immunotherapy, more particularly to the field of adoptive cell therapy (ACT).
Simon BORNSCHEIN, Peggy SOTIROPOULOU, Eytan BREMAN, Mikhail STEKLOV
Filed: 4 May 20
Utility
Method and Apparatus for Automated Independent Parallel Batch-processing of Cells
16 Sep 21
A cell processing device is provided that is suitable for performing independent concurrent processing of a plurality of cell preparations, the cell processing device comprising: (I) a cell processing station; and (II) a plurality of cell processing modules, wherein the plurality of cell processing modules engage and communicate with the cell processing station; wherein each of the plurality of cell processing modules comprises discrete processing compartments defined within, the processing compartments comprising: (i) a reagent pack, the reagent pack comprising one or more reagent vessels; d (ii) one or more fluidic cartridges, each fluidic cartridge comprising one or more cell processing compartments and a cell incubation compartment, wherein each of the processing compartments is in fluid communication with each other.
Diederik Hauwaerts, Stefano Baila, Valérie Steenwinckel, Benjamin Demoulin, Kenneth Galbraith, Richard Grant, Mark Rob
Filed: 21 Jul 17
Utility
Compositions and Methods for Improving Persistence of Cells for Adoptive Transfer
10 Jun 21
The present application relates to the field of immunotherapy, more particularly to the manufacture of cells for adoptive cell therapy.
David GILHAM, Simon BORNSCHEIN, Susanna RAITANO
Filed: 5 Dec 18
Utility
Pooling Signaling and Costimulatory Domains In Flexible Car Design
11 Mar 21
The present application relates to the field of immunotherapy, more particularly to the field of chimeric antigen receptors (CARs).
David GILHAM, Jennifer BOLSÉE, Lorraine SPRINGUEL
Filed: 14 Dec 18
Utility
Steering control mechanism for catheter
16 Nov 20
This document relates to catheter-based therapeutic apparatus and methods for directing therapy within the body of a subject.
Christian Homsy, Jean-Pierre Latere-Dwan'isa
Filed: 7 Apr 14
Utility
Injection catheter for delivering a therapeutic agent into a substrate
20 Apr 20
The invention relates to an injection catheter for delivering a therapeutic agent into a substrate, comprising one or more lumens and a curved delivery element, said lumen serving as a guide for said curved delivery element outside of the substrate; said curved delivery element comprising openings on its distal tip, said distal tip comprising a distal zone and a proximal zone, said injection catheter being characterized in that the specific surface in said distal zone of said distal tip of said curved delivery element is higher than the specific surface in said proximal zone of said distal tip of said curved delivery element.
Jean-Pierre Latere Dwan'isa, Christian Homsy, Jozef Bartunek, Roland Gordon-Beresford
Filed: 19 Apr 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first